According to the Appendix, SOLSTICE met its primary endpoint, demonstrating clinically meaningful HbA1c reductions over 26 weeks in adults with type 2 diabetes. In obesity and overweight, the Phase IIb VISTA trial (NCT06579092) assessed multiple oral doses of elecoglipron versus placebo, using coprimary endpoints of percentage change in body weight and the proportion of participants achieving at least 5% weight loss at 26 weeks
In Nalm6 cells, which grow in suspension, the treatment with L-BSO increased the sensitivity of ADH5 cells to FA (Fig
Two components of this metabolic environment, gut microbiota composition and lipid mediator (oxylipin) profiles, play increasingly recognized roles in anabolic signaling, endothelial function, inflammation, and muscle adaptation (93)
Bloating symptoms can typically include a tight, full feeling in the stomach, pain or pressure from trapped gas or stool, visible swelling or distention, constipation, nausea, and, in some cases, fever